Project Grant HT9425261E059
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1,821,750 project grant under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2026 through April 30, 2030. The grant supports research and development of a predictive spatial assay designed to identify and eliminate unnecessary therapeutic interventions in patients with primary ductal carcinoma in situ (DCIS). This initiative represents part of DHA's...
- Federal Grant Award Summary The Leland Stanford Junior University received a Project Grant award of $832,270 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2028. The award supports high-throughput in vivo lung cancer pharmacogenomics research to be conducted at Stanford's Palo Alto, California facility. This research initiative aligns with the DHA's mission to advance biomedical solutions...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $3,128,801 under the Military Medical Research and Development program (CFDA 12.420) to develop a blood test for measuring sleep deprivation and circadian time. The award, effective June 1, 2025, through May 31, 2028, supports advanced biomedical research directed at transforming healthcare for military service members and the broader public. This research initiative...
- Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $1,054,071 Project Grant under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The award funds research and development activities focused on novel inhibitors of NEMO-like kinase for the treatment of Diamond Blackfan Anemia, a rare blood disorder. Stanford will conduct this research at its Palo Alto, California campus,...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a $4.23 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) for research titled "Advancing Cure Rates for Infantile Acute Lymphoblastic Leukemia." The award, effective June 1, 2025, with a completion date of May 31, 2029, funds basic and applied biomedical research designed to improve therapeutic outcomes for pediatric acute lymphoblastic...
- This federal Project Grant award of $4,277,148.00 from the Defense Health Agency under the CFDA Program 12.420 - Military Medical Research and Development supports research to identify molecular predictors of risk and objectively validate the evolution of ductal carcinoma in situ (DCIS). The award, effective September 30, 2023, with an ultimate completion date of September 29, 2027, will be performed at Stanford University. Through this grant, Stanford University will conduct basic,...
- The Defense Health Agency awarded The Leland Stanford Junior University a $1,500,084 project grant under the Military Medical Research and Development program to support research on detecting cartilage surface degeneration using photon counting CT and solute transport modeling. This grant will fund research from July 1, 2023 through June 30, 2027 aimed at transforming military and public health care through innovative medical solutions applicable to battlefield conditions. The Military Medical...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...
- This $370,866 Formula Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research conducted by The Leland Stanford Junior University, a prominent private research university. The grant will fund a 1-year project to uncover synthetically lethal genes that could be targeted in lung cancer in the presence of protein folding stress, with the goal of transforming healthcare for military service members...
- This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
The Defense Health Agency (DHA) awarded The Leland Stanford Junior University a Project Grant totaling $1,528,250 under the Military Medical Research and Development program (CFDA 12.420) to develop a predictive spatial assay designed to eliminate unnecessary therapies in primary ductal carcinoma in situ (DCIS). The award, effective May 1, 2026 through April 30, 2030, supports advanced biomedical research aimed at improving oncologic treatment outcomes through precision medicine approaches. This research initiative will be conducted at Stanford University's Palo Alto, California facilities and represents the DHA's investment in innovative diagnostic and therapeutic technologies to transform healthcare delivery for military service members and the broader American public. The Military Medical Research and Development program supports hypothesis-driven basic, applied, and advanced biomedical research addressing critical health challenges, including oncology, with typical award durations of three to four years. Stanford University's award reflects the institution's established capability in delivering sophisticated cancer research solutions and its competitive standing within the federal research ecosystem. The project is subject to standard DHA oversight, including pre-application and full application competitive review processes emphasizing both technical merit and military relevance, with performance period potentially extensible for up to 12 months without additional funding if warranted.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.5m | 4/2/26 |